Repetitive Stretch-Induced Myocardial Stiffening in Chronic Coronary Artery Disease
慢性冠状动脉疾病中反复牵拉引起的心肌硬化
基本信息
- 批准号:10588929
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesivesAgingAngiographyAngioplastyAreaAutopsyBiochemicalBiologicalBlood capillariesCardiacCardiovascular DiseasesCardiovascular systemCause of DeathCessation of lifeChronicClassificationClinicalCollagenCongestive Heart FailureCoronaryCoronary ArteriosclerosisCoronary VesselsDataDepositionDevelopmentDiseaseDyspneaEFRACEvidence based treatmentExertionExhibitsExposure toExtracellular MatrixFamily suidaeFeedbackFibrillar CollagenFibroblastsFibrosisFrequenciesFunctional disorderGlycoproteinsGlycosaminoglycansGoalsHealthcare SystemsHeart DiseasesHeart failureHeterogeneityHospitalizationHypertensionImplantInvestigationIschemiaLeftLeft Ventricular MassLeft ventricular structureLinkMechanicsMedicineModelingMonitorMorbidity - disease rateMyocardialMyocardial tissueMyocardiumObesityOutcomePatientsPhenotypePhenylephrinePopulationPrevalenceProcessPrognosisPropertyQuality of lifeResearchRiskRisk FactorsRoleStenosisStretchingSymptomsTelemetryTestingVascularizationVentricularVeteransclinically relevantcohortcomorbiditycoronary fibrosisdisabilityeffective therapyexperienceexperimental studyhemodynamicsimprovedinterstitialmilitary veteranmortalitymultidisciplinarynew therapeutic targetnovelnovel therapeutic interventionporcine modelpreservationpressurepreventtherapy designtreatment strategy
项目摘要
Abstract
Heart failure with preserved ejection fraction (HFpEF) has emerged as the most common form of heart failure
among Veterans, yet there is currently a paucity of treatment strategies that have been proven to improve
prognosis. A primary reason for the lack of effective therapies for this increasingly prevalent condition is the
limited understanding of mechanisms underlying myocardial stiffening, a key pathophysiologic component of
HFpEF that is directly linked to exertional dyspnea, the cardinal presenting symptom of the disorder. The
overarching goal of this proposal is to address this problem by elucidating the role of repetitive stretch-induced
remodeling of the cardiac extracellular matrix (ECM) as a mechanistic link between chronic coronary artery
disease (CAD) and HFpEF, two conditions that are extremely common in the Veteran population. Based on our
preliminary data from multiple clinically-relevant swine models of heart disease, we hypothesize that
myocardial stiffening develops in the setting of chronic CAD as a result of repetitive stretch-induced
fibrosis caused by intermittent elevations in left ventricular (LV) preload. If so, this may explain why such
a large proportion of the HFpEF population exhibits angiographically-significant epicardial CAD (~60-70% in
multiple cohorts) and might have important clinical implications related to the use of coronary revascularization
in these patients, since the reversibility of repetitive stretch-induced myocardial fibrosis is unclear.
To test this hypothesis, we will utilize a porcine model of chronic epicardial CAD to better understand how
exposure to episodic preload elevation influences remodeling of ischemic and non-ischemic regions of the left
ventricle in this setting. In Aim 1, implantable telemetry will be used for continuous hemodynamic monitoring to
quantify the frequency of preload elevation in swine with either multi-vessel (MV-CAD) or single-vessel CAD
(SV-CAD) and determine whether repetitive preload elevation is required for the development of interstitial
fibrosis in remote, non-ischemic myocardium. In Aim 2, percutaneous angioplasty will be performed in swine
with MV-CAD and swine with SV-CAD to determine if repetitive stretch-induced stiffening associated with MV-
CAD dictates whether LV fibrosis is reversed by revascularization. Post-mortem analysis of isolated cardiac
fibroblasts and decellularized cardiac ECM from these models will be completed in Aim 3 to assess the mechanistic
role of ECM-dependent fibroblast activation in repetitive stretch-induced LV stiffening and determine whether
increased ECM stiffness per se causes protracted fibroblast activation that promotes persistent fibrosis through a
self-sustaining positive feedback loop.
These aims will be addressed by a multi-disciplinary investigative team using an integrative research
approach that combines serial investigation of regional and global myocardial mechanics with ex vivo mechanical
and biological analysis of myocardial tissue strips, isolated cardiac fibroblasts, and decellularized cardiac ECM.
Collectively, these experiments in translationally-relevant swine models of heart disease are expected to
establish repetitive stretch-induced ECM remodeling as a mechanistic link between CAD and HFpEF and
facilitate the development of novel therapeutic strategies to reduce the unacceptably high morbidity and mortality
of Veterans with these increasingly prevalent conditions.
抽象的
射血分数保留的心力衰竭(HFpEF)已成为最常见的心力衰竭形式
在退伍军人中,但目前缺乏已被证明可以改善病情的治疗策略
预后。这种日益流行的疾病缺乏有效疗法的主要原因是
对心肌僵硬的机制了解有限,心肌僵硬是心肌梗塞的关键病理生理学组成部分
HFpEF 与劳力性呼吸困难直接相关,劳力性呼吸困难是该疾病的主要症状。这
该提案的总体目标是通过阐明重复拉伸诱导的作用来解决这个问题
心脏细胞外基质(ECM)的重塑作为慢性冠状动脉之间的机械联系
疾病 (CAD) 和 HFpEF,这两种疾病在退伍军人群体中极为常见。基于我们的
根据来自多种临床相关猪心脏病模型的初步数据,我们假设
慢性 CAD 患者由于反复牵拉引起心肌僵硬
左心室(LV)前负荷间歇性升高引起的纤维化。如果是这样,这可以解释为什么这样
很大一部分 HFpEF 人群表现出血管造影显着的心外膜 CAD(约 60-70%
多个队列),并且可能具有与冠状动脉血运重建相关的重要临床意义
在这些患者中,由于重复拉伸引起的心肌纤维化的可逆性尚不清楚。
为了验证这一假设,我们将利用慢性心外膜 CAD 的猪模型来更好地了解如何
暴露于间歇性前负荷升高会影响左侧缺血和非缺血区域的重塑
心室在这种情况下。在目标 1 中,植入式遥测技术将用于连续血流动力学监测,以
使用多血管 (MV-CAD) 或单血管 CAD 量化猪预载升高的频率
(SV-CAD) 并确定间隙的形成是否需要重复预载抬高
远端非缺血心肌纤维化。在目标 2 中,将在猪身上进行经皮血管成形术
使用 MV-CAD 和猪使用 SV-CAD 来确定重复拉伸引起的僵硬是否与 MV-
CAD 决定了左室纤维化是否可以通过血运重建来逆转。离体心脏的尸检分析
来自这些模型的成纤维细胞和脱细胞心脏 ECM 将在目标 3 中完成,以评估其机制
ECM 依赖性成纤维细胞激活在重复牵拉引起的 LV 僵硬中的作用,并确定是否
ECM 硬度增加本身会导致成纤维细胞活化延长,从而通过
自我维持的正反馈循环。
这些目标将由多学科调查小组利用综合研究来实现
将区域和整体心肌力学的系列研究与离体力学相结合的方法
以及心肌组织条、分离的心脏成纤维细胞和脱细胞心脏ECM的生物学分析。
总的来说,这些在与转化相关的心脏病猪模型中进行的实验预计将
建立重复拉伸诱导的 ECM 重塑作为 CAD 和 HFpEF 之间的机械联系
促进新治疗策略的开发,以降低令人难以接受的高发病率和死亡率
患有这些日益普遍的病症的退伍军人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian Raymond Weil其他文献
Brian Raymond Weil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian Raymond Weil', 18)}}的其他基金
Immunomodulatory Therapy After Resuscitation From Cardiac Arrest
心脏骤停复苏后的免疫调节治疗
- 批准号:
10334812 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Immunomodulatory Therapy After Resuscitation From Cardiac Arrest
心脏骤停复苏后的免疫调节治疗
- 批准号:
10543188 - 财政年份:2022
- 资助金额:
-- - 项目类别:
相似国自然基金
聚电解质络合作用调控的高初黏性大豆蛋白粘合剂构建及增强机制研究
- 批准号:52303059
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氮杂环丙烷基聚多硫化物可逆粘合剂的分子设计与制备
- 批准号:22378080
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
仿深共晶溶剂小分子类低温粘合剂的设计制备及粘附机制研究
- 批准号:22308299
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载MUR仿生脂质体粘合剂靶向调控荷菌巨噬细胞IFI204/ARMCX3/Caspase-11焦亡抑制创伤性骨髓炎发生的机制研究
- 批准号:82372421
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
多酚功能化壳聚糖基组织粘合剂构建及其能量耗散机制探究
- 批准号:82302389
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Volumetric analysis of epithelial morphogenesis with high spatiotemporal resolution
高时空分辨率上皮形态发生的体积分析
- 批准号:
10586534 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Novel Algorithm and Data Strategies to detect and Predict atrial fibrillation for post-stroke patients (NADSP)
用于检测和预测中风后患者心房颤动的新算法和数据策略 (NADSP)
- 批准号:
10561108 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging Patients
使用再生骨粘合剂加速老年患者骨愈合的四肢骨折改进治疗方法的商业化
- 批准号:
10822079 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Strain-Programmed Bioadhesive Patch for Enhanced Diabetic Wound Healing
用于增强糖尿病伤口愈合的应变程序生物粘附贴片
- 批准号:
10818916 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification
用于肌肉干细胞极性和命运规范的工程不对称水凝胶
- 批准号:
10405716 - 财政年份:2022
- 资助金额:
-- - 项目类别: